Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology

Laura A. Geer, Benny F G Pycke, David M. Sherer, Ovadia Abulafia, Rolf Halden

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Amniotic fluid (AF) is a biological medium uniquely suited for the study of early exposure of the human fetus to environmental contaminants acquired by the mother before and during pregnancy. Traditional diagnostic applications of AF have focused almost exclusively on the diagnosis of genetic aberrations such as Trisomy-21 and on heritable diseases in high-risk pregnancies. Since more than 50 anthropogenic compounds have been detected in AF, there is considerable potential in utilizing fetal protein biomarkers as indicators of health effects related to prenatal toxic exposure. Here, we focus on preterm birth (PTB) to illustrate opportunities and limitations of using AF as a diagnostic matrix. Representing a pervasive public health challenge worldwide, PTB cannot be managed simply by improving hygiene and broadening access to healthcare. This is illustrated by 15-year increases of PTB in the U.S. from 1989 to 2004. AF is uniquely suited as a matrix for early detection of the association between fetal exposures and PTB due to its fetal origin and the fact that it is sampled from women who are at higher risk of PTB. This critical review shows the occurrence in AF of a number of xenobiotics, including endocrine-disrupting compounds (EDCs), which are known or may reasonably be expected to shorten fetal gestation. It is not yet known whether EDCs, including bisphenol A, phytoestrogens, and polychlorinated biphenyls (PCBs), can affect the expression of proteins considered viable or potential biomarkers for the onset of PTB. As such, the diagnostic value of AF is broad and has not yet been fully explored for prenatal diagnosis of pregnancies at risk from toxic, environmental exposures and for the elucidation of mechanisms underlying important public health challenges including PTB.

Original languageEnglish (US)
Pages (from-to)470-481
Number of pages12
JournalEnvironmental Research
Volume136
DOIs
StatePublished - Jan 1 2015

Fingerprint

etiology
Premature Birth
Amniotic Fluid
pregnancy
Pregnancy
Fluids
fluid
Poisons
Biomarkers
Public health
biomarker
public health
Public Health
Fetal Proteins
Phytoestrogens
High-Risk Pregnancy
matrix
protein
Polychlorinated Biphenyls
Environmental Exposure

Keywords

  • Amniotic fluid
  • Endocrine-disrupting chemicals
  • Fetal origin of disease
  • Preterm birth
  • Protein biomarker

ASJC Scopus subject areas

  • Environmental Science(all)
  • Biochemistry

Cite this

Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology. / Geer, Laura A.; Pycke, Benny F G; Sherer, David M.; Abulafia, Ovadia; Halden, Rolf.

In: Environmental Research, Vol. 136, 01.01.2015, p. 470-481.

Research output: Contribution to journalArticle

@article{cd1c67e95618431fa5c1a6bac94c8676,
title = "Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology",
abstract = "Amniotic fluid (AF) is a biological medium uniquely suited for the study of early exposure of the human fetus to environmental contaminants acquired by the mother before and during pregnancy. Traditional diagnostic applications of AF have focused almost exclusively on the diagnosis of genetic aberrations such as Trisomy-21 and on heritable diseases in high-risk pregnancies. Since more than 50 anthropogenic compounds have been detected in AF, there is considerable potential in utilizing fetal protein biomarkers as indicators of health effects related to prenatal toxic exposure. Here, we focus on preterm birth (PTB) to illustrate opportunities and limitations of using AF as a diagnostic matrix. Representing a pervasive public health challenge worldwide, PTB cannot be managed simply by improving hygiene and broadening access to healthcare. This is illustrated by 15-year increases of PTB in the U.S. from 1989 to 2004. AF is uniquely suited as a matrix for early detection of the association between fetal exposures and PTB due to its fetal origin and the fact that it is sampled from women who are at higher risk of PTB. This critical review shows the occurrence in AF of a number of xenobiotics, including endocrine-disrupting compounds (EDCs), which are known or may reasonably be expected to shorten fetal gestation. It is not yet known whether EDCs, including bisphenol A, phytoestrogens, and polychlorinated biphenyls (PCBs), can affect the expression of proteins considered viable or potential biomarkers for the onset of PTB. As such, the diagnostic value of AF is broad and has not yet been fully explored for prenatal diagnosis of pregnancies at risk from toxic, environmental exposures and for the elucidation of mechanisms underlying important public health challenges including PTB.",
keywords = "Amniotic fluid, Endocrine-disrupting chemicals, Fetal origin of disease, Preterm birth, Protein biomarker",
author = "Geer, {Laura A.} and Pycke, {Benny F G} and Sherer, {David M.} and Ovadia Abulafia and Rolf Halden",
year = "2015",
month = "1",
day = "1",
doi = "10.1016/j.envres.2014.09.031",
language = "English (US)",
volume = "136",
pages = "470--481",
journal = "Environmental Research",
issn = "0013-9351",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Use of amniotic fluid for determining pregnancies at risk of preterm birth and for studying diseases of potential environmental etiology

AU - Geer, Laura A.

AU - Pycke, Benny F G

AU - Sherer, David M.

AU - Abulafia, Ovadia

AU - Halden, Rolf

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Amniotic fluid (AF) is a biological medium uniquely suited for the study of early exposure of the human fetus to environmental contaminants acquired by the mother before and during pregnancy. Traditional diagnostic applications of AF have focused almost exclusively on the diagnosis of genetic aberrations such as Trisomy-21 and on heritable diseases in high-risk pregnancies. Since more than 50 anthropogenic compounds have been detected in AF, there is considerable potential in utilizing fetal protein biomarkers as indicators of health effects related to prenatal toxic exposure. Here, we focus on preterm birth (PTB) to illustrate opportunities and limitations of using AF as a diagnostic matrix. Representing a pervasive public health challenge worldwide, PTB cannot be managed simply by improving hygiene and broadening access to healthcare. This is illustrated by 15-year increases of PTB in the U.S. from 1989 to 2004. AF is uniquely suited as a matrix for early detection of the association between fetal exposures and PTB due to its fetal origin and the fact that it is sampled from women who are at higher risk of PTB. This critical review shows the occurrence in AF of a number of xenobiotics, including endocrine-disrupting compounds (EDCs), which are known or may reasonably be expected to shorten fetal gestation. It is not yet known whether EDCs, including bisphenol A, phytoestrogens, and polychlorinated biphenyls (PCBs), can affect the expression of proteins considered viable or potential biomarkers for the onset of PTB. As such, the diagnostic value of AF is broad and has not yet been fully explored for prenatal diagnosis of pregnancies at risk from toxic, environmental exposures and for the elucidation of mechanisms underlying important public health challenges including PTB.

AB - Amniotic fluid (AF) is a biological medium uniquely suited for the study of early exposure of the human fetus to environmental contaminants acquired by the mother before and during pregnancy. Traditional diagnostic applications of AF have focused almost exclusively on the diagnosis of genetic aberrations such as Trisomy-21 and on heritable diseases in high-risk pregnancies. Since more than 50 anthropogenic compounds have been detected in AF, there is considerable potential in utilizing fetal protein biomarkers as indicators of health effects related to prenatal toxic exposure. Here, we focus on preterm birth (PTB) to illustrate opportunities and limitations of using AF as a diagnostic matrix. Representing a pervasive public health challenge worldwide, PTB cannot be managed simply by improving hygiene and broadening access to healthcare. This is illustrated by 15-year increases of PTB in the U.S. from 1989 to 2004. AF is uniquely suited as a matrix for early detection of the association between fetal exposures and PTB due to its fetal origin and the fact that it is sampled from women who are at higher risk of PTB. This critical review shows the occurrence in AF of a number of xenobiotics, including endocrine-disrupting compounds (EDCs), which are known or may reasonably be expected to shorten fetal gestation. It is not yet known whether EDCs, including bisphenol A, phytoestrogens, and polychlorinated biphenyls (PCBs), can affect the expression of proteins considered viable or potential biomarkers for the onset of PTB. As such, the diagnostic value of AF is broad and has not yet been fully explored for prenatal diagnosis of pregnancies at risk from toxic, environmental exposures and for the elucidation of mechanisms underlying important public health challenges including PTB.

KW - Amniotic fluid

KW - Endocrine-disrupting chemicals

KW - Fetal origin of disease

KW - Preterm birth

KW - Protein biomarker

UR - http://www.scopus.com/inward/record.url?scp=84911950240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911950240&partnerID=8YFLogxK

U2 - 10.1016/j.envres.2014.09.031

DO - 10.1016/j.envres.2014.09.031

M3 - Article

C2 - 25460669

AN - SCOPUS:84911950240

VL - 136

SP - 470

EP - 481

JO - Environmental Research

JF - Environmental Research

SN - 0013-9351

ER -